List of Tables
Table 1. Global Treatment of Blastic-Phase CML Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Treatment of Blastic-Phase CML Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Treatment of Blastic-Phase CML Market Competitive Situation by Manufacturers in 2025
Table 4. Global Treatment of Blastic-Phase CML Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Treatment of Blastic-Phase CML Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Treatment of Blastic-Phase CML Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Treatment of Blastic-Phase CML Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Treatment of Blastic-Phase CML Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Treatment of Blastic-Phase CML, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Treatment of Blastic-Phase CML, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Treatment of Blastic-Phase CML, Product Types and Applications
Table 12. Global Key Manufacturers of Treatment of Blastic-Phase CML, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Treatment of Blastic-Phase CML Companies by Tier (Tier 1, Tier 2, Tier 3), based on Treatment of Blastic-Phase CML Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Treatment of Blastic-Phase CML Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Treatment of Blastic-Phase CML Sales by Region (K Units), 2021–2026
Table 18. Global Treatment of Blastic-Phase CML Sales Market Share by Region (2021–2026)
Table 19. Global Treatment of Blastic-Phase CML Sales by Region (K Units), 2027–2032
Table 20. Global Treatment of Blastic-Phase CML Sales Market Share by Region (2027–2032)
Table 21. Global Treatment of Blastic-Phase CML Revenue by Region (US$ Million), 2021–2026
Table 22. Global Treatment of Blastic-Phase CML Revenue Market Share by Region (2021–2026)
Table 23. Global Treatment of Blastic-Phase CML Revenue by Region (US$ Million), 2027–2032
Table 24. Global Treatment of Blastic-Phase CML Revenue Market Share by Region (2027–2032)
Table 25. North America Treatment of Blastic-Phase CML Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Treatment of Blastic-Phase CML Sales by Country (K Units), 2021–2026
Table 27. North America Treatment of Blastic-Phase CML Sales by Country (K Units), 2027–2032
Table 28. North America Treatment of Blastic-Phase CML Revenue by Country (US$ Million), 2021–2026
Table 29. North America Treatment of Blastic-Phase CML Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Treatment of Blastic-Phase CML Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Treatment of Blastic-Phase CML Sales by Country (K Units), 2021–2026
Table 32. Europe Treatment of Blastic-Phase CML Sales by Country (K Units), 2027–2032
Table 33. Europe Treatment of Blastic-Phase CML Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Treatment of Blastic-Phase CML Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Treatment of Blastic-Phase CML Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Treatment of Blastic-Phase CML Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Treatment of Blastic-Phase CML Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Treatment of Blastic-Phase CML Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Treatment of Blastic-Phase CML Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Treatment of Blastic-Phase CML Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Treatment of Blastic-Phase CML Sales by Country (K Units), 2021–2026
Table 42. Latin America Treatment of Blastic-Phase CML Sales by Country (K Units), 2027–2032
Table 43. Latin America Treatment of Blastic-Phase CML Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Treatment of Blastic-Phase CML Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Treatment of Blastic-Phase CML Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Treatment of Blastic-Phase CML Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Treatment of Blastic-Phase CML Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Treatment of Blastic-Phase CML Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Treatment of Blastic-Phase CML Revenue by Country (US$ Million), 2027–2032
Table 50. Global Treatment of Blastic-Phase CML Sales (K Units) by Type (2021–2026)
Table 51. Global Treatment of Blastic-Phase CML Sales (K Units) by Type (2027–2032)
Table 52. Global Treatment of Blastic-Phase CML Sales Market Share by Type (2021–2026)
Table 53. Global Treatment of Blastic-Phase CML Sales Market Share by Type (2027–2032)
Table 54. Global Treatment of Blastic-Phase CML Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Treatment of Blastic-Phase CML Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Treatment of Blastic-Phase CML Revenue Market Share by Type (2021–2026)
Table 57. Global Treatment of Blastic-Phase CML Revenue Market Share by Type (2027–2032)
Table 58. Global Treatment of Blastic-Phase CML Price (US$/Unit) by Type (2021–2026)
Table 59. Global Treatment of Blastic-Phase CML Price (US$/Unit) by Type (2027–2032)
Table 60. Global Treatment of Blastic-Phase CML Sales (K Units) by Application (2021–2026)
Table 61. Global Treatment of Blastic-Phase CML Sales (K Units) by Application (2027–2032)
Table 62. Global Treatment of Blastic-Phase CML Sales Market Share by Application (2021–2026)
Table 63. Global Treatment of Blastic-Phase CML Sales Market Share by Application (2027–2032)
Table 64. Global Treatment of Blastic-Phase CML Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Treatment of Blastic-Phase CML Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Treatment of Blastic-Phase CML Revenue Market Share by Application (2021–2026)
Table 67. Global Treatment of Blastic-Phase CML Revenue Market Share by Application (2027–2032)
Table 68. Global Treatment of Blastic-Phase CML Price (US$/Unit) by Application (2021–2026)
Table 69. Global Treatment of Blastic-Phase CML Price (US$/Unit) by Application (2027–2032)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Sanofi Treatment of Blastic-Phase CML Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Treatment of Blastic-Phase CML Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Bristol Myers Squibb Company Information
Table 81. Bristol Myers Squibb Description and Business Overview
Table 82. Bristol Myers Squibb Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Bristol Myers Squibb Treatment of Blastic-Phase CML Product
Table 84. Bristol Myers Squibb Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Novartis Treatment of Blastic-Phase CML Product
Table 89. Novartis Recent Developments/Updates
Table 90. Takeda Pharmaceuticals Company Information
Table 91. Takeda Pharmaceuticals Description and Business Overview
Table 92. Takeda Pharmaceuticals Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Takeda Pharmaceuticals Treatment of Blastic-Phase CML Product
Table 94. Takeda Pharmaceuticals Recent Developments/Updates
Table 95. Apotex Company Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Apotex Treatment of Blastic-Phase CML Product
Table 99. Apotex Recent Developments/Updates
Table 100. Dr. Reddy's Laboratories Company Information
Table 101. Dr. Reddy's Laboratories Description and Business Overview
Table 102. Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Product
Table 104. Dr. Reddy's Laboratories Recent Developments/Updates
Table 105. Chia Tai Tianqing Pharmaceutical Company Information
Table 106. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 107. Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Product
Table 109. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 110. Qilu Pharmaceutical Company Information
Table 111. Qilu Pharmaceutical Description and Business Overview
Table 112. Qilu Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Qilu Pharmaceutical Treatment of Blastic-Phase CML Product
Table 114. Qilu Pharmaceutical Recent Developments/Updates
Table 115. CSPC Ouyi Pharmaceutical Company Information
Table 116. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 117. CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Product
Table 119. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 120. Lunan Pharmaceutical Company Information
Table 121. Lunan Pharmaceutical Description and Business Overview
Table 122. Lunan Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Lunan Pharmaceutical Treatment of Blastic-Phase CML Product
Table 124. Lunan Pharmaceutical Recent Developments/Updates
Table 125. HanHui Pharmaceuticals Company Information
Table 126. HanHui Pharmaceuticals Description and Business Overview
Table 127. HanHui Pharmaceuticals Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. HanHui Pharmaceuticals Treatment of Blastic-Phase CML Product
Table 129. HanHui Pharmaceuticals Recent Developments/Updates
Table 130. Hansoh Pharmaceutical Company Information
Table 131. Hansoh Pharmaceutical Description and Business Overview
Table 132. Hansoh Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Hansoh Pharmaceutical Treatment of Blastic-Phase CML Product
Table 134. Hansoh Pharmaceutical Recent Developments/Updates
Table 135. Beacon Pharmaceuticals Company Information
Table 136. Beacon Pharmaceuticals Description and Business Overview
Table 137. Beacon Pharmaceuticals Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Beacon Pharmaceuticals Treatment of Blastic-Phase CML Product
Table 139. Beacon Pharmaceuticals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Treatment of Blastic-Phase CML Distributors List
Table 143. Treatment of Blastic-Phase CML Customers List
Table 144. Treatment of Blastic-Phase CML Market Trends
Table 145. Treatment of Blastic-Phase CML Market Drivers
Table 146. Treatment of Blastic-Phase CML Market Challenges
Table 147. Treatment of Blastic-Phase CML Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Treatment of Blastic-Phase CML
Figure 2. Global Treatment of Blastic-Phase CML Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Treatment of Blastic-Phase CML Market Share by Type: 2025 & 2032
Figure 4. Chemotherapy Product Picture
Figure 5. Targeted Therapy with TKIs Product Picture
Figure 6. Allogeneic BMT or SCT Product Picture
Figure 7. Others Product Picture
Figure 8. Global Treatment of Blastic-Phase CML Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Treatment of Blastic-Phase CML Market Share by Application: 2025 & 2032
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Others
Figure 13. Global Treatment of Blastic-Phase CML Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Treatment of Blastic-Phase CML Market Size (US$ Million), 2021–2032
Figure 15. Global Treatment of Blastic-Phase CML Sales (K Units), 2021–2032
Figure 16. Global Treatment of Blastic-Phase CML Average Price (US$/Unit), 2021–2032
Figure 17. Treatment of Blastic-Phase CML Report Years Considered
Figure 18. Treatment of Blastic-Phase CML Sales Share by Manufacturers in 2025
Figure 19. Global Treatment of Blastic-Phase CML Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Treatment of Blastic-Phase CML Players: Market Share by Revenue in Treatment of Blastic-Phase CML in 2025
Figure 21. Treatment of Blastic-Phase CML Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Treatment of Blastic-Phase CML Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Treatment of Blastic-Phase CML Sales Market Share by Country (2021–2032)
Figure 24. North America Treatment of Blastic-Phase CML Revenue Market Share by Country (2021–2032)
Figure 25. United States Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Treatment of Blastic-Phase CML Sales Market Share by Country (2021–2032)
Figure 28. Europe Treatment of Blastic-Phase CML Revenue Market Share by Country (2021–2032)
Figure 29. Germany Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Treatment of Blastic-Phase CML Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Treatment of Blastic-Phase CML Revenue Market Share by Region (2021–2032)
Figure 36. China Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Treatment of Blastic-Phase CML Sales Market Share by Country (2021–2032)
Figure 44. Latin America Treatment of Blastic-Phase CML Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Treatment of Blastic-Phase CML Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Treatment of Blastic-Phase CML Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Treatment of Blastic-Phase CML Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Treatment of Blastic-Phase CML by Type (2021–2032)
Figure 55. Global Revenue Market Share of Treatment of Blastic-Phase CML by Type (2021–2032)
Figure 56. Global Treatment of Blastic-Phase CML Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Treatment of Blastic-Phase CML by Application (2021–2032)
Figure 58. Global Revenue Market Share of Treatment of Blastic-Phase CML by Application (2021–2032)
Figure 59. Global Treatment of Blastic-Phase CML Price (US$/Unit) by Application (2021–2032)
Figure 60. Treatment of Blastic-Phase CML Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
